This HTML5 document contains 198 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/
n11http://dx.doi.org/10.5606/

Statements

Subject Item
wd:Q97426362
rdf:type
wikibase:Item
schema:description
artikel ilmiah artigo científico tudományos cikk 2019年学术文章 научни чланак scienca artikolo 2019 nî lūn-bûn 2019年学术文章 article scientifique vedecký článok artigo científico 2019年學術文章 articol științific videnskabelig artikel udgivet 12. december 2019 bài báo khoa học 2019年學術文章 научная статья мақолаи илмӣ vitskapeleg artikkel scientific article published on 12 December 2019 2019年学术文章 article scientific scientific article published on 12 December 2019 2019年學術文章 artigo científico vitenskapelig artikkel artikulong pang-agham vědecký článek wetenschappelijk artikel articolo scientifico บทความทางวิทยาศาสตร์ επιστημονικό άρθρο artículu científicu bilimsel makale teaduslik artikkel artykuł naukowy 2019年学术文章 vetenskaplig artikel מאמר מדעי tieteellinen artikkeli article científic 2019年学术文章 სამეცნიერო სტატია مقالة علمية نشرت في 12 ديسمبر 2019 2019年の論文 2019 թվականի դեկտեմբերի 12-ին հրատարակված գիտական հոդված 2019年學術文章 научна статия наукова стаття, опублікована в грудні 2019 2019년 논문 научни чланак scientific article published on 12 December 2019 2019年學術文章 ১২ ডিসেম্বর ২০১৯-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ artikull shkencor wissenschaftlicher Artikel naučni članak artículo científico publicado en 2019 2019年学术文章
p:P577
wds:Q97426362-CDC3F001-BBF7-4CD1-8F68-6719D98AF082
wdt:P577
2019-12-12T00:00:00Z
p:P2860
wds:Q97426362-01E692F8-724C-4F5A-A7D1-D4F6D9933D8B wds:Q97426362-FAAE25E8-D1F9-4603-B647-FB1923F6EA42 wds:Q97426362-FE460EBF-90D1-476F-B521-8CE80DDA28AC wds:Q97426362-FFA59215-7AF7-4C56-BDC9-FB7FC4B43E61 wds:Q97426362-F66FA754-F8DB-477F-8FD8-D43CDC6EB3C0 wds:Q97426362-DF71EC61-C649-4FB5-907A-987A515153AF wds:Q97426362-DF932E5D-0B3E-430C-AC70-444C56ECF61C wds:Q97426362-E30B101E-38C3-4286-B333-B5289ACB0589 wds:Q97426362-D0CE5C35-7352-49BC-9EAE-282185A1A74C wds:Q97426362-D73D9967-A8F9-4556-90C0-2B21628D7276 wds:Q97426362-D875F13D-591C-4B5A-9A16-17C861CC297F wds:Q97426362-DC77C805-393B-466B-9F8C-6D5F115AC2F0 wds:Q97426362-CA82B955-4F63-4F42-B7E5-91FA72EA94DE wds:Q97426362-CDACEF21-8102-4B1E-9515-010611440E26 wds:Q97426362-C52B9E23-6274-4F36-82DB-1E721FF93F68 wds:Q97426362-C8B87FDA-0EA7-4F4E-8584-361BD450DD73 wds:Q97426362-B6A481C0-29E9-498D-86F7-A8C54C214AC7 wds:Q97426362-B88A7804-85E5-4EE1-AC95-0695B70A0F8E wds:Q97426362-B8AC4246-8D90-40D0-8BBD-D40C4320D578 wds:Q97426362-BB62497F-BE11-41E1-AC10-C70FA920EBAC wds:Q97426362-AE6273C2-8ED2-45DB-80E4-FCCFDA2E52AB wds:Q97426362-AEE48A60-962C-4FDD-8C4D-BD1D90832B4C wds:Q97426362-AFAE0891-8A6C-43B9-B3C9-62D127A1BC8F wds:Q97426362-B1DF06A6-4C44-41F4-BF11-96FC14CB15C0 wds:Q97426362-A39428C9-C42E-4B17-9758-15E72E2E0455 wds:Q97426362-A7EAA62A-8A6D-4DF7-8358-A700A67D4F9A wds:Q97426362-A7F7C6F0-0D54-4665-8ACA-E17E1D6801A4 wds:Q97426362-AC14B7F8-8568-4F60-A09F-29B1FA090C8D wds:Q97426362-88F5FC52-5998-46D3-BEA2-B671A62966F0 wds:Q97426362-8EF81F32-A813-4FA2-9B44-B9A931F75D47 wds:Q97426362-9D7E23FD-9FC1-44EE-A350-F87700CA49F1 wds:Q97426362-66EB3727-9C07-45A3-A96A-F2DA8985ECE7 wds:Q97426362-6E060E26-F15D-41FC-951E-9075A6A14C13 wds:Q97426362-7EF4D184-8C95-46D3-92B4-8CCCFBBC6A10 wds:Q97426362-51334658-8F3D-41AE-ABE8-B20E0A77B7FE wds:Q97426362-58000473-5305-4296-9CF4-A36C3724A56A wds:Q97426362-5E526E85-0EDB-48B5-9FDD-B418968F611F wds:Q97426362-63C844A7-F284-4A07-B0DC-67B8F3507229 wds:Q97426362-38A8D3CA-158B-47DD-9A48-E1DB263D58B8 wds:Q97426362-3E526048-CE49-4752-89D6-FE9DA23AD47F wds:Q97426362-2748BD3D-8EEC-4DBB-B4D8-69BC1940B726 wds:Q97426362-2EB31738-C4A1-4D93-AF55-D00C981BECCE wds:Q97426362-2F99A7B4-A11B-40A5-B59C-0398CB4B8F9F wds:Q97426362-34668A59-8CA0-4BFD-9E7D-ED4CB3FAD155 wds:Q97426362-15346966-6AAE-43DA-BE4D-123A3F6FE558 wds:Q97426362-18177510-004F-4C9B-AF99-C32D72E643B0 wds:Q97426362-26D27410-14D7-442F-A08F-271131C4A00A wds:Q97426362-0F85DB88-027D-40C5-A849-6E22695D8A42 wds:Q97426362-102F09EB-F1ED-40D2-B01B-276BF4FAF7F0 wds:Q97426362-1189A23F-C2CD-4329-A800-5A10A2858B80
wdt:P2860
wd:Q74389718 wd:Q35072317 wd:Q84897051 wd:Q62601973 wd:Q85325207 wd:Q33412915 wd:Q34455896 wd:Q36348763 wd:Q44338705 wd:Q37141430 wd:Q57907773 wd:Q38104683 wd:Q28240666 wd:Q27021871 wd:Q53624942 wd:Q29620160 wd:Q90202151 wd:Q83389363 wd:Q39449741 wd:Q39456469 wd:Q37020336 wd:Q34231902 wd:Q45881942 wd:Q35925359 wd:Q80048498 wd:Q37230504 wd:Q28174751 wd:Q37741798 wd:Q88292346 wd:Q24632951 wd:Q45868646 wd:Q53647405 wd:Q53551807 wd:Q38416654 wd:Q87211442 wd:Q53533989 wd:Q38122121 wd:Q39023182 wd:Q87417887 wd:Q86704919 wd:Q90007363 wd:Q86646346 wd:Q37838098 wd:Q44588720 wd:Q53190445 wd:Q64897464 wd:Q40131133 wd:Q45857473 wd:Q29614696 wd:Q39934417
p:P2093
wds:Q97426362-77E1FA1E-201F-4D38-913C-4932E638BEBC wds:Q97426362-C75F1559-80C5-43F5-AB7E-1F92A420D24E wds:Q97426362-F0C61296-0FA8-4773-AC7C-F73BB5D191B2
wdt:P2093
Mandana Khodashahi Maryam Sahebari Zahra Rezaieyazdi
rdfs:label
Comparison of the Therapeutic Effects of Rivaroxaban Versus Warfarin in Antiphospholipid Syndrome: A Systematic Review Comparison of the Therapeutic Effects of Rivaroxaban Versus Warfarin in Antiphospholipid Syndrome: A Systematic Review
skos:prefLabel
Comparison of the Therapeutic Effects of Rivaroxaban Versus Warfarin in Antiphospholipid Syndrome: A Systematic Review Comparison of the Therapeutic Effects of Rivaroxaban Versus Warfarin in Antiphospholipid Syndrome: A Systematic Review
schema:name
Comparison of the Therapeutic Effects of Rivaroxaban Versus Warfarin in Antiphospholipid Syndrome: A Systematic Review Comparison of the Therapeutic Effects of Rivaroxaban Versus Warfarin in Antiphospholipid Syndrome: A Systematic Review
p:P1476
wds:Q97426362-BC0BC327-54E1-4AFA-9E71-B46C376F7750
wdt:P1476
Comparison of the Therapeutic Effects of Rivaroxaban Versus Warfarin in Antiphospholipid Syndrome: A Systematic Review
p:P304
wds:Q97426362-FBC93578-D61F-4FAD-8B20-5E36D21467BF
wdt:P304
107-116
p:P31
wds:Q97426362-3A9F303D-8382-4796-A9E3-3281C1A3E442
wdt:P31
wd:Q13442814
p:P921
wds:Q97426362-84AAC141-8B5E-484F-B2C2-EE5ECF4C1819 wds:Q97426362-21358EA0-DC03-48C5-92B5-AB3332FC02FB
wdt:P921
wd:Q407431 wd:Q582207
p:P698
wds:Q97426362-F4784FE2-2629-4DA2-A128-ADD1BFC5E515
wdtn:P698
n8:32637926
wdt:P698
32637926
p:P1433
wds:Q97426362-EA052F05-F505-4C91-A5FA-1E6C7B0F9E2A
wdt:P1433
wd:Q96319521
p:P433
wds:Q97426362-E162C8D2-30E7-4589-A895-F34D57816F7D
p:P478
wds:Q97426362-360E20D0-0977-4214-80CC-09E611997E58
wdt:P433
1
wdt:P478
35
p:P356
wds:Q97426362-053DDD01-5602-43E4-98EC-B3639110CA91
wdtn:P356
n11:ARCHRHEUMATOL.2020.7375
wdt:P356
10.5606/ARCHRHEUMATOL.2020.7375
p:P932
wds:Q97426362-CE43E8FC-00F2-404B-B60A-1CAF4CD66973
wdt:P932
7322308